Results
|
|
1.
|
|
|
|
2.
|
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
All authors: - Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
|
|
|
20.
|
|
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. MedStar authors:
Year: 2022
Citation: - Cell. 185(14):2591-2608.e30, 2022 07 07.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Agrawal P, Agustinus A, Amin AD, Andreatta M, Atkins MB, Azizi E, Bakhoum SF, Banu M, Barrera I, Berhe S, Bi WL, Biermann J, Bruce JN, Caldwell B, Canoll P, Caprio LA, Carmona SJ, Carvajal R, Chazotte M, Chen F, Davies MA, Driver J, Eigentler T, Fullerton BT, Gretarsson KH, Hernando E, Hibshoosh H, Ho P, Humala N, Ibarra-Arellano MA, Ingham M, Izar B, Karz A, Khan SA, Koch PD, Lu C, Luoma AM, Macosko EZ, Mahajan A, Mangipudy VS, Melms JC, Mu M, Nair A, Nguyen TTT, Rapisuwon S, Ribas A, Rocken M, Rogava M, Sahu V, Schapiro D, Schwartz GK, Shah SB, Siegelin M, Slingluff CL Jr, Tagore S, Vaccaro DH, Walsh ZH, Wang Y, Wunnemann F
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial. MedStar authors:
Year: 2022
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bernard GR, Bistran-Hall AJ, Brady EJ, Carnahan RH, Casey JD, Cataldo VD, Chappell JD, Chauhan L, Cohn CS, Crowe JE Jr, de Wit M, Denison MR, El Atrouni W, Fremont RD, Gilchuk P, Ginde AA, Harris ES, Henning DJ, Higgins C, Hoda D, Ipe TS, Jaiswal SJ, Johnson NJ, Jones AE, Laguio-Vila M, Lindsell CJ, Mallada J, Mammen MJ, McWilliams C, Mucha S, O'Neal HR Jr, Pannu SR, Passive Immunity Trial for Our Nation (PassITON) Investigators, Pulley JM, Qiao X, Raval JS, Rhoads JP, Rice TW, Schrager H, Schrantz SJ, Self WH, Shanholtz C, Shapiro NI, Shenoy A, Stevens LJ, Stewart TG, Sutton RE, Thomas CB, Thomsen I, Wang L, Wheeler AP, Yoder SM
|
|
|
28.
|
|
|
|
29.
|
Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy. MedStar authors:
- Chen, Kevin Y
- Peravali, Monica
- Rao, Suman
- Veytsman, Irina
Year: 2022
Citation: - Clinical Lung Cancer. 2022 Apr 29
Institution:
- MedStar Franklin Square Medical Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
All authors: - Chen KY, Geng X, Giaccone G, Joshi I, Kim C, Liu SV, Peravali M, Rao S, Veytsman I
|
|
|
30.
|
A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon's National Surgical Quality Improvement Project (NSQIP). [Review] MedStar authors:
- Boisvert, Marc
- Deldar, Romina
- Fan, Kenneth L
- Sogunro, Olutayo
Year: 2022
Citation: - Breast Cancer Research & Treatment. 2022 May 27
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Breast Oncology Fellowship
- MedStar General Surgery Residency
- MedStar Georgetown University Hospital/MedStar Washington Hospital Center
- Surgery/Plastic Surgery
Medline publication type:
All authors: - Abu El Hawa AA, Aminpour N, Boisvert M, Deldar R, Fan KL, Haffner ZK, Sogunro O, Towfighi P
|
|
|
31.
|
Early Outpatient Treatment for Covid-19 with Convalescent Plasma. MedStar authors:
Year: 2022
Citation: - New England Journal of Medicine. 386(18):1700-1711, 2022 05 05.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Abinante M, Anjan S, Appel LJ, Baksh SN, Blair JE, Bloch EM, Broderick PB, Cachay ER, Casadevall A, Cluzet VC, Cordisco ME, Cruser D, Currier JS, Ehrhardt S, Ford DE, Forthal DN, Foster EC, Fukuta Y, Gawad AL, Gebo KA, Gerber JM, Gniadek TJ, Greenblatt B, Hammel J, Hammitt LL, Hanley DF, Heath SL, Huaman MA, Jabs DA, Karlen N, Kassaye SG, Klein SL, Laeyendecker O, Lane K, Lau B, Levine AC, Marshall CE, McBee NA, Meisenberg BR, Mosnaim GS, Oei K, Patel B, Paxton JH, Pekosz A, Petrini JR, Rausch W, Raval JS, Roth M, Shade DM, Shenoy AG, Shoham S, Singh A, Spivak ES, Sullivan DJ, Sutcliffe CG, Tobian AAR, Yarava A, Zand MS
|
|
|
32.
|
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?. MedStar authors:
Year: 2022
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Abinante M, Adamski J, Anjan S, Bloch EM, Broderick PB, Cachay ER, Casadevall A, Cruser D, Forthal D, Fukuta Y, Gawad A, Gebo KA, Gerber J, Gniadek TJ, Hanley DF, Heath SL, Huaman MA, Kafka K, Kassaye SG, Lane K, Levine A, Marshall C, McBee N, Meisenberg BR, Metcalf RA, Mosnaim GS, Patel B, Paxton JH, Raval JS, Reisler RB, Shenoy A, Shoham S, Sullivan D, Tobian AAR, Yarava A, Zand M, Ziman A
|
|
|
33.
|
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection. MedStar authors:
Year: 2022
Citation: - Jci Insight. 7(5), 2022 03 08.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Aliyu L, Betenbaugh M, Blankson JN, Bloch EM, Broderick P, Caputo CA, Casadevall A, Cox AL, Cramer SM, Dziedzic A, Garliss C, Gebo KA, Gniadek TJ, Hanley D, Hauk P, Heath SL, Jedlicka AE, Klein SL, Koley S, Laeyendecker O, Majewska NI, Mosnaim G, Mostafa HH, Park HS, Patel B, Pekosz A, Rousseau KE, Sachithanandham J, Shapiro JR, Shenoy A, Shoham S, Sitaras I, Spivak ES, Sullivan D, Suwanmanee S, Thakar M, Tobian AA, Woldemeskel BA
|
|
|
34.
|
Two methodologies of the rendezvous procedure to establish ureteral continuity from a delayed ureteral leak following pelvic surgery. MedStar authors:
- Aljundi, Moutasem
- Chang, George
- Khan, Arshad A
- Sabri, Saher S
- Sugarbaker, Paul H
Year: 2022
Citation: - Surgical Oncology. 40:101697, 2022 Mar.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
All authors: - Aljundi MN, Chang G, Khan AA, Sabri S, Sugarbaker PH
|
|
|
35.
|
|
|
|
36.
|
Reply to a. Avan et Al. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Kiermaier A, Swain S
|
|
|
37.
|
|
|
|
38.
|
A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials. MedStar authors:
- Banda, Deliya R
- Libin, Alexander V
- Swain, Sandra M
- Wang, Hong
Year: 2012
Citation: - Oncologist. 17(5):708-14, 2012.
Institution:
- MedStar Health Research Institute
- MedStar National Rehabilitation Network
- Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Banda DR, Libin AV, Swain SM, Wang H
|
|
|
39.
|
|
|
|
40.
|
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. MedStar authors:
- Sugarbaker, Paul H
- Yan, Tristan D
Year: 2012
Citation: - Journal of Clinical Oncology. 30(20):2449-56, 2012 Jul 10.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Baratti D, Barrios P, Ceelen WP, Chua TC, de Hingh IH, Deraco M, Elias D, Gilly FN, Glehen O, Gomez Portilla A, Gonzalez-Moreno S, Levine EA, Liauw W, Moran BJ, Morris DL, Pelz JO, Piso P, Sardi A, Sugarbaker PH, Van Der Speeten K, Yan TD
|
|
|
41.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
42.
|
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. MedStar authors:
Year: 2012
Citation: - Lancet. 379(9814):432-44, 2012 Feb 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Meta-Analysis
- Research Support, Non-U.S. Gov't
All authors: - Albain K, Bergh J, Clarke M, Cutter D, Darby S, Davies C, Di Leo A, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Godwin J, Gray R, McGale P, Pan HC, Peto R, Piccart M, Pritchard K, Swain S, Taylor C, Wang YC
|
|
|
43.
|
Twenty-five year results of the national cancer institute randomized breast conservation trial. MedStar authors:
Year: 2012
Citation: - Breast Cancer Research & Treatment. 132(1):197-203, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Camphausen K, Dan T, Danforth DN, Glatstein E, Lippman ME, Lita E, Sciuto L, Shih J, Simone NL, Smith SL, Swain SM
|
|
|
44.
|
Pazopanib for the treatment of breast cancer. [Review] MedStar authors:
Year: 2012
Citation: - Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Review
All authors: - Amiri-Kordestani L, Swain SM, Tan AR
|
|
|
45.
|
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
|
|
|
46.
|
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors:
Year: 2012
Citation: - New England Journal of Medicine. 366(4):310-20, 2012 Jan 26.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
|
47.
|
Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer. MedStar authors:
Year: 2012
Citation: - Clinical Breast Cancer. 12(4):232-9, 2012 Aug.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Duong QN, Hewitt SM, Hoffman HJ, Levine PH, Portera CC, Swain SM, Takikita M, Yang SX
|
|
|
48.
|
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors:
Year: 2012
Citation: - Lancet Oncology. 13(7):734-42, 2012 Jul.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P
|
|
|
49.
|
|
|
|
50.
|
Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. MedStar authors:
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, Hoffman HJ, Huerta E, LaVerda NL, Levine PH, Patierno SR, Swain S, Young HA
|
|
|
51.
|
Drug discount program. MedStar authors:
Year: 2013
Citation: - JAMA. 310(15):1626-7, 2013 Oct 16.
Institution: - Washington Cancer Institute
Medline publication type:
|
|
|
52.
|
|
|
|
53.
|
|
|
|
54.
|
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
Year: 2013
Citation: - Oncologist. 18(3):257-64, 2013.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
|
|
|
55.
|
|
|
|
56.
|
|
|
|
57.
|
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. MedStar authors:
Year: 2012
Citation: - Proceedings of the National Academy of Sciences of the United States of America. 109(18):7067-72, 2012 May 1.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bezrookove V, Bienvenu G, Billings P, Climent J, Dar AA, De Semir D, Debs R, Federman S, Haqq C, Kashani-Sabet M, Leong SP, Meyer Tamguney TM, Miller JR 3rd, Nosrati M, Rangel J, Sagebiel RW, Thummala S, Tong S, Venna S
|
|
|
58.
|
What is your diagnosis? Anal mucosal melanoma. MedStar authors:
Year: 2012
Citation: - Cutis. 89(3):112, 116, 140, 2012 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
- Case Reports
- Journal Article
All authors: - Minor DS, Shoo BA, Venna SS
|
|
|
59.
|
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
Year: 2013
Citation: - Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
|
|
|
60.
|
|
|
|
61.
|
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
Year: 2013
Citation: - Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
|
|
|
62.
|
|
|
|
63.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
|
64.
|
Vemurafenib-induced DRESS. MedStar authors:
- Jang, Sekwon
- Nasabzadeh, Teresa
- Pichard, Dominique C
- Wenk, Kurt S
Year: 2013
Citation: - JAMA Dermatology. 149(10):1242-3, 2013 Oct.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Case Reports
- Journal Article
All authors: - Jang S, Nasabzadeh T, Pichard DC, Venna SS, Wenk KS
|
|
|
65.
|
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL
|
|
|
66.
|
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. MedStar authors:
Year: 2013
Citation: - Cancer Medicine. 2(2):178-84, 2013 Apr.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
All authors: - Ayed FB, Ayoub WB, Brown LM, Eissa S, Gail M, Kantor ED, Khalafallah S, Khaled H, Merajver S, Omar S, Schairer C, Soliman AS, Swain SM
|
|
|
67.
|
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
Year: 2013
Citation: - Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
|
|
|
68.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
|
69.
|
Reply to E.J. Moylan et al. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(6):606-7, 2014 Feb 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Geyer CE Jr, Swain SM, Tang G
|
|
|
70.
|
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
Year: 2014
Citation: - Cancer. 120(17):2657-64, 2014 Sep 1.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, Non-U.S. Gov't
All authors: - Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
|
|
|
71.
|
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
Year: 2013
Citation: - Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
|
|
|
72.
|
Building bridges to conquer cancer. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(30):3731-6, 2013 Oct 20.
Institution: - Washington Cancer Institute
Medline publication type:
|
|
|
73.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
|
74.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
|
75.
|
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2014
Citation: - Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
|
|
|
76.
|
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - BMC Cancer. 14:307, 2014.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B
|
|
|
77.
|
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
78.
|
|
|
|
79.
|
Treatment of HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(20):1964-5, 2015 May 14.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Swain SM
|
|
|
80.
|
|
|
|
81.
|
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
82.
|
Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. [Review] MedStar authors:
Year: 2015
Citation: - JAMA Dermatology. 151(2):212-8, 2015 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
All authors: - Chen SC, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kim CC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Swetter SM, Veledar E, Venna SS
|
|
|
83.
|
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors:
Year: 2015
Citation: - Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N
|
|
|
84.
|
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA
|
|
|
85.
|
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
Year: 2015
Citation: - Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
|
86.
|
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. MedStar authors:
Year: 2016
Citation: - American Journal of Surgical Pathology. 40(1):14-26, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Consensus Development Conference
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Carr NJ, Cecil TD, Chapman S, Gonzalez-Moreno S, Mohamed F, Moran BJ, Peritoneal Surface Oncology Group International, Sobin LH, Sugarbaker PH, Taflampas P
|
|
|
87.
|
|
|
|
88.
|
Deleterious BRCA1/2 mutations in an urban population of Black women. MedStar authors:
- Fries, Melissa
- Lynce, Filipa
Year: 2015
Citation: - Breast Cancer Research & Treatment. 153(1):201-9, 2015 Aug.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - DeMarco T, Fries M, Isaacs C, Lynce F, Peshkin BN, Smith KL, Stein J, Wang H, Wang Y
|
|
|
89.
|
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. MedStar authors:
Year: 2015
Citation: - JAMA Oncology. 1(3):296-305, 2015 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Adams-Campbell LL, Aragaki AK, Chlebowski RT, Johnson KC, Kaunitz A, Lessin LS, Manson JE, Nassir R, O'Sullivan MJ, Prentice RL, Rohan TE, Simon MS, Stefanick ML, Wactawski-Wende J
|
|
|
90.
|
|
|
|
91.
|
Improving Documentation of Pain Management at MedStar Washington Cancer Institute. MedStar authors:
- Agrawal, Sundeep
- Beasley, Janet
- Chokshi, Puja
- Harkness, Jaylon
- Heller, Stephanie
- Jang, Sekwon
- Ranpura, Vishal
- Self, Linda
- Swain, Sandra M
- Wood, Lynne
- Yerasi, Charan
Year: 2015
Citation: - Journal of oncology practice/American Society of Clinical Oncology. 11(2):155-7, 2015 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Agrawal S, Beasley J, Chokshi P, Harkness J, Heller S, Jang S, Ranpura V, Self L, Swain SM, Wood L, Yerasi C
|
|
|
92.
|
|
|
|
93.
|
Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC). MedStar authors:
Year: 2016
Citation: - Surgery. 159(3):728-35, 2016 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Carmona-Saez P, Delgado M, Garcia Puche JL, Gonzalez AM, Lorente JA, Melero JT, Ortega FG, Serrano MJ, Sugarbaker PH
|
|
|
94.
|
|
|
|
95.
|
|
|
|
96.
|
Skin-Colored, Dome-Shaped Papule on the Upper Lip. MedStar authors:
- Gamble, Misty
- Reserva, Jeave
Year: 2015
Citation: - American Family Physician. 91(12):869-70, 2015 Jun 15.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Case Reports
- Journal Article
All authors: - Gamble M, Reserva JL, Venna SS
|
|
|
97.
|
|
|
|
98.
|
|
|
|
99.
|
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
|
|
|
100.
|
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Herbolsheimer, Pia M
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Shara, Nawar M
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
- Washington Cancer Institute
- Washington Cancer Institute A
- Washington Cancer Instituteia
Department:
- MedStar Heart Institute
- MedStar Heart Institute
Medline publication type:
All authors: - Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
|
